|
How small molecule can take apart Alzheimer's disease protein fibers
May 16, 2008PHILADELPHIA - Researchers from the University of Pennsylvania School of Medicine have shown, in unprecedented detail, how a small molecule is able to selectively take apart abnormally folded protein fibers connected to Alzheimer's disease and prion diseases. The findings appear online this week in the Proceedings of the National Academy of Sciences. Finding a way to dismantle misfolded proteins has implications for new treatments for a host of neurodegenerative diseases.
Abnormal accumulation of amyloid fibers and other misfolded forms in the brain cause neurodegenerative diseases. Similarly, build-up of abnormally folded prion proteins between neurons causes the human version of mad cow disease, Creutzfeldt-Jakob disease.
"Surprisingly, a small molecule called DAPH selectively targets the areas that hold fibers together, and converts fibers to a form that is unable to grow. Normally fibers grow from their ends, but the drug stops this activity," says senior author James Shorter, PhD, Assistant Professor of Biochemistry and Biophysics. "Our data suggest that it is possible to generate effective small molecules that can attack amyloid fibers, which are associated with so many devastating diseases."
The researchers are now working on how DAPH acts as a wedge to stop the fibers from growing. "Presumably DAPH fits very neatly into the crevices between fiber subunits," explains Shorter. "When we grow yeast cells with the prion in the presence of DAPH, they begin to lose the prion. We also saw this in the test tube using pure fibers. The small molecule directly remodels fiber architecture. We've really been able to get at the mechanism by which DAPH, or any small molecule, works for the first time." DAPH was originally found in a screen of small molecules that reduce amyloid-beta toxicity in the lab of co-author Vernon Ingram, Shorter's collaborator at the Massachusetts Institute of Technology (MIT).
In a test tube, if a small amount of amyloid or prion fiber is added to the normal form of the protein, it converts it to the fiber form. But when DPAH is added to the mix, the yeast prion protein does not aggregate into fibers. "It's essentially stopping fiber formation in its tracks," says Huan Wang, first author and research specialist in Shorter's lab. "We were surprised to see two very different proteins, amyloid-beta and Sup35, sensitive to this same small molecule."
The next step is to identify more potent DAPH variants with greater selectivity for deleterious amyloids. Since some amyloids may turn out to be beneficial - for example, one form may be involved in long-term memory formation - it will be necessary to find a drug that does not hit all amyloids indiscriminately. "We'd need one that hits only problem amyloids, and DAPH gives us a hint that such selectivity is possible" says Shorter.
University of Pennsylvania School of Medicine
The researchers are now working on how DAPH acts as a wedge to stop the fibers from growing. "Presumably DAPH fits very neatly into the crevices between fiber subunits," explains Shorter. "When we grow yeast cells with the prion in the presence of DAPH, they begin to lose the prion. We also saw this in the test tube using pure fibers. The small molecule directly remodels fiber architecture. We've really been able to get at the mechanism by which DAPH, or any small molecule, works for the first time." DAPH was originally found in a screen of small molecules that reduce amyloid-beta toxicity in the lab of co-author Vernon Ingram, Shorter's collaborator at the Massachusetts Institute of Technology (MIT).
In a test tube, if a small amount of amyloid or prion fiber is added to the normal form of the protein, it converts it to the fiber form. But when DPAH is added to the mix, the yeast prion protein does not aggregate into fibers. "It's essentially stopping fiber formation in its tracks," says Huan Wang, first author and research specialist in Shorter's lab. "We were surprised to see two very different proteins, amyloid-beta and Sup35, sensitive to this same small molecule."
The next step is to identify more potent DAPH variants with greater selectivity for deleterious amyloids. Since some amyloids may turn out to be beneficial - for example, one form may be involved in long-term memory formation - it will be necessary to find a drug that does not hit all amyloids indiscriminately. "We'd need one that hits only problem amyloids, and DAPH gives us a hint that such selectivity is possible" says Shorter.
University of Pennsylvania School of Medicine
Prion News and Current Prion Events RSSEurope develops new technologies to boost health of livestock
A range of new technologies including genetic modification (GM) and RNA Interference are being deployed to improve the health of farm animals in a series of European and global initiatives. The ground was laid for a European platform to develop new treatments that exploit these technologies at a recent workshop organised by the European Science Foundation (ESF).
New insights into the diversity of Creutzfeldt-Jakob disease agents
Researchers from the United Kingdom and France have identified four separate biochemical subgroups in a selection of cases of Creutzfeldt-Jakob disease.
Prions link cholesterol to neurodegeneration
Prion infection of neurons increases the free cholesterol content in cell membranes. A new study published in the online open access journal BMC Biology suggests that disturbances in membrane cholesterol may be the mechanism by which prions cause neurodegeneration and could point to a role for cholesterol in other neurodegenerative diseases.
Scripps scientists develop new tests that identify lethal prion strains quickly and accurately
One of the new in vitro tests, called the Standard Scrapie Cell Assay, measures prion infectivity levels in a highly accurate and extremely rapid way, producing results in less than two weeks.
UIC chemists characterize Alzheimer's neurotoxin structure
Amyloid plaques, the hallmark of Alzheimer's disease, are clumps of fiber-like misfolded proteins which many experts think cause this devastating neurodegenerative disease.
First high-res 3D structures of mammalian HSP90 protein solved
Dr. Dan Gewirth, Hauptman-Woodward senior research scientist, has just solved the structure of the first mammalian GRP94 protein implicated in immune diseases such as sepsis, AIDS and certain cancers.
New prion protein discovered by Canadian scientists may offer insight into mad cow disease
Scientists have discovered a new protein that may offer fresh insights into brain function in mad cow disease. "Our team has defined a second prion protein called 'Shadoo', that exists in addition to the well-known prion protein called 'PrP' " said Professor David Westaway, director of the Centre for Prions and Protein Folding Diseases at the University of Alberta.
Newly discovered antibody may be body's natural defense against Alzheimer's
In an important advance in the battle against Alzheimer's disease, physician-scientists at NewYork-Presbyterian Hospital/Weill Cornell Medical Center have identified naturally occurring antibodies in human blood that may help to defend against this form of dementia as well as other neurodegenerative diseases.
NMR advance relies on microscopic detector
Detecting the molecular structure of a tiny protein using nuclear magnetic resonance (NMR) currently requires two things: a million-dollar machine the size of a massive SUV, and a large sample of the protein under study.
Scientists identify prion's infectious secret
Researchers have known for decades that certain neurodegenerative diseases, such as mad cow disease or its human equivalent, Cruetzfeldt-Jakob disease, result from a kind of infectious protein called a prion.
More Prion News Articles
 | The Family That Couldn't Sleep: A Medical Mystery by D.T. Max |
 | Things a Woman Should Know About Style (Things A Woman Should Know Series) by Karen Homer |
 | A Well-Dressed Gentleman's Pocket Guide by Oscar Lenius |
 | Deadly Feasts: The "Prion" Controversy and the Public's Health by Richard Rhodes |
 | The Last Dog on Earth by Daniel Ehrenhaft |
 | The Return of Hyman Kaplan (Prion Humour Classics) by Leo Rosten |
 | Sex Lives of the Rich and Famous (Sex Lives) by Nigel Cawthorne |
 | COGNITIVE EVOLUTION: The Biological Imprint of Applied Intelligence by Alice Travis |
 | Sex Lives of the Popes (Sex Lives) by Nigel Cawthorne |
 | The English Gentleman (Prion Humour Classics) by Douglas Sutherland |
| © 2008 BrightSurf.com |